PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPsychomotor agitation
MeSH D011595 - psychomotor agitation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011596:Psychomotor disorders
0 Companies
0 Drugs
Success rate
D020820:Dyskinesias
54 Companies
12 Drugs
$
Success rate
D000096762:Aberrant motor behavior in dementia
0 Companies
0 Drugs
Success rate
D011595: 
Psychomotor agitation
48 Companies
3 Drugs
$
Success rate
D017109:Drug-induced akathisia
23 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDexmedetomidine Dexmedetomidine  2017-11-28   
Propofol Propofol  2000-09-19   
PadagisMidazolam Midazolam  2005-05-02   
MylanDexmedetomidine Dexmedetomidine  2014-08-18   
RocheMidazolam Versed  1998-10-15   
SandozDexmedetomidine Dexmedetomidine  2016-06-14   
UCBMidazolam Nayzilam 2028-01-18 2019-05-17   
Dr Reddys LaboratoriesPropofol Propofol  2018-11-15   
Zydus TherapeuticsDexmedetomidine Dexmedetomidine  2018-02-27   
Sun Pharmaceutical IndustriesMidazolam Midazolam  2002-03-15   
HospiraMidazolam Midazolam  2000-06-20   
Dexmedetomidine Precedex 2032-01-04 1999-12-17   
Propofol Propofol  2006-03-17   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
100%
2/2
Phase 3
60%
9/15
Approved: 4Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Dexpramipexole,
Ccb,
Pbo
Roche
Midazolam,
Midazolam maleate
UCB
Midazolam,
Midazolam maleate,
Benzocaine,
Dexpramipexole
Bristol Myers Squibb
Midazolam,
Midazolam maleate
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use